scispace - formally typeset
S

Satoru Miyano

Researcher at Tokyo Medical and Dental University

Publications -  874
Citations -  45801

Satoru Miyano is an academic researcher from Tokyo Medical and Dental University. The author has contributed to research in topics: Gene & Gene regulatory network. The author has an hindex of 84, co-authored 811 publications receiving 38723 citations. Previous affiliations of Satoru Miyano include University of Paderborn & Institute of Medical Science.

Papers
More filters
Journal ArticleDOI

Whole Exome Sequencing to Predict Response to Hypomethylating Agents in MDS

TL;DR: A cohort of 168 patients with MDS who received either azacitidine or decitabine for the presence of somatic mutations was screened, finding mutant CBL and PPFIA2 to be strongly associated with response, whereas mutant U2AF1/2, SF3B1 and PRPF8 were stronglyassociated with refractoriness.
Journal ArticleDOI

A likelihood-free filtering method via approximate Bayesian computation in evaluating biological simulation models

TL;DR: A novel method that utilizes the approximate Bayesian computation in filtering the data and self-organizing ensemble Kalman filter in constructing the prior distributions of the parameter values is proposed and applied to real observation data in rat circadian oscillation to demonstrate the usefulness in practical situations.
Proceedings ArticleDOI

Simulation analysis for the effect of light-dark cycle on the entrainment in circadian rhythm

TL;DR: The simulation results suggested that the interacting circadian feedback network at the molecular level is essential for phase dependence of the light effects, observed in mammalian behavior.
Journal ArticleDOI

Recent computational drug repositioning strategies against SARS-CoV-2

TL;DR: In this paper , the authors present a review of drug repositioning and combination efforts towards providing better handling of COVID-19 and find that graph theory and neural network were the most used strategies with high potential towards drug reppositioning for COVID19.